- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical productsBusiness Overview: a) FBL is engaged in development and manufacturing of pharmaceuticals, biotechnology and environmental solutions used across various industries. It is a global player in manufacturing of Vitamin D3 in all its formats and has a non-China...
Fermenta Biotech has scheduled a one-to-one physical meeting in Mumbai, where company officials will engage with investors. This interaction will focus on information from publicly available Press Releases and Investor Presentations. The company explicitly stated that no unpublished price sensitive information will be shared during these meetings, ensuring transparent communication...
Fermenta Biotech Limited has announced the publication of a newspaper notice for a Special Window for Transfer and Dematerialisation of Physical Securities. This notice was published in Business Standard and Sakal. This initiative is crucial for shareholders who still hold their shares in physical form, as it provides a specific...
Fermenta Biotech has scheduled an investor meeting on August 21, 2026, in Mumbai. Company officials will participate in a one-to-one physical interaction with investors. The discussions will be limited to information already publicly available through Press Releases and Investor Presentations, with the company confirming that no unpublished price sensitive information...
Fermenta Biotech Limited has received an upgraded credit rating from CARE Ratings. The company's long-term bank facilities of ₹166.73 crore (previously ₹118.94 crore) have been upgraded to CARE BBB+; Stable from CARE BBB; Stable. Additionally, short-term bank facilities totaling ₹6.25 crore are now rated CARE A2, an upgrade from CARE...